AstraZeneca Chairman Says Drug Tariffs Would Harm Patients

Tariffs on pharmaceuticals would hurt patients and drugs should be exempt from these levies, AstraZeneca Plc’ Chairman Michel Demaré said.

US President Donald Trump has warned that tariffs on pharmaceutical companies — which weren’t part of the so-called reciprocal tariffs he imposed and then paused — are imminent.

“Medicines should be exempted from any kind of tariffs because at the end this is just harming patients, health systems and restricting health equity,” Demaré said at Astra’s annual general meeting on Friday.

The British drugmaker announced last year that it was investing $3.5 billion in the US. Since then, ...